B. Riley Securities Maintains Buy on WAVE Life Sciences, Lowers Price Target to $22

Benzinga Newsdesk www.benzinga.com Negative 52.2%

Neg 52.2% Neu 0% Pos 0%

B. Riley Securities analyst Madison El-Saadi maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $31 to $22.